Rising obesity among the women population to drive the growth of the global PCOS treatment market
According to TechSci Research report, “Global PCOS Treatment Market By Surgery (Ovarian Wedge Resection, Cyst Aspiration, Laparoscopic Ovarian Drilling), By Drug (Ovulation Inducing Agents, Insulin-Sensitizing Agents, Oral Contraceptives, Antiandrogens, Anti-Depressants, Insulin-Sensitizing Agents, Anti-Obesity Drugs, Others), By Diagnosis (Pelvic Examination, Ultrasound, Blood Tests), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics), By Region, Forecast & Opportunities, 2025”, the global PCOS treatment market is expected to grow at a formidable rate of around 8.63% during the forecast period on account of the rising awareness pertaining to diseases and reproductive health among the population. Additionally, initiatives taken by various government and non-government organizations for spreading awareness and providing schemes and services for the welfare of women are further expected to positively impact the growth of the market over the next few years. Furthermore, easy access to PCOS therapeutics, growing demand for PCOS medication, and the rising popularity of combination therapy are further expected to foster the growth of the market through 2025. However, the easy availability of generics and off-the-label drugs might hinder the growth of the market during the forecast period. Additionally, the lack of approved therapeutics and side effects of the available drugs might hamper the growth of the market over the next few years. Also, at present no targeted therapy is available for this syndrome & it is only controlled through medication and some surgical procedures.
Browse 1 market data Tables and 37 Figures spread through 110 Pages and an in-depth TOC on “ Global PCOS Treatment Market” https://www.techsciresearch.com/report/pcos-treatment-market/4683.html
The global PCOS treatment market is segmented based on surgery, drug, diagnosis, end-user, company, and region. The drug on the market can be categorized into ovulation-inducing agents, oral contraceptives, antiandrogens, anti-depressants, insulin-sensitizing agents, anti-obesity drugs, others. The oral contraceptive drugs are expected to register the fastest growth through the forecast period owing to their widespread use as the first line of treatment for PCOS. These contraceptives help in regulating the menstruation cycles in the patient. Additionally, these are helpful in treating severe menstrual pain, Premenstrual syndrome (PMS), and acne, which are common symptoms of Polycystic ovary syndrome.
Bristol-Myers Squibb Company, Bayer AG, Pfizer, Inc., Abbott Laboratories, Inc., Merck & Co., Inc., Sanofi SA, AstraZeneca Plc, Novartis AG, Teva Pharmaceutical Industries Limited, Ferring Pharmaceuticals, Inc., and others are some of the leading players operating in global PCOS treatment market. The companies operating in the market are using organic strategies such as product launches, mergers, and collaborations to boost their share. For instance, in January 2106, AstraZeneca announced that they have started a startup for women’s health treatment and invested USD 62 million in drug development for polycystic ovarian disorder.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4683
Customers can also request for 10% free customization on this report.
“North America is expected to dominate the global PCOS treatment market during the forecast period, owing to the presence of well-developed healthcare infrastructure in the region. Additionally, availability of skilled medical personnel coupled with large PCOS patient pool especially in the United States is further expected to create lucrative opportunities for the market players over the next few years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.“Global PCOS Treatment Market By Surgery (Ovarian Wedge Resection, Cyst Aspiration, Laparoscopic Ovarian Drilling), By Drug (Ovulation Inducing Agents, Insulin-Sensitizing Agents, Oral Contraceptives, Antiandrogens, Anti-Depressants, Insulin-Sensitizing Agents, Anti-Obesity Drugs, Others), By Diagnosis (Pelvic Examination, Ultrasound, Blood Tests), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics), By Region, Forecast & Opportunities, 2025”,” has evaluated the future growth potential of global PCOS treatment market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the global PCOS treatment market
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Copyright © 2014 - 2021 The Global Indian New Network (TGINN)